Skip to content

13F-HR filed by Cheyne Capital Management (UK) LLP

Cheyne Capital Management (UK) LLP filed this 13F-HR for the quarter ended 2014-12-31, filed 2015-02-11, with 56 holding rows worth $380,287,000.

Accession
0001140361-15-005300
Filed
2015-02-11
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2014

A holdings report, 56 entries on the cover page, a total value of $380,287,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $380,287,000 with VALUE read as thousands by filing date, 13F file number 028-12483. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
DIRECTV25490A309COM434,586$37,676,000thousands by filing date
DRESSER-RAND GROUP INC261608103COM460,207$37,629,000thousands by filing date
CUBIST PHARMACEUTICALS INC229678107COM373,372$37,593,000thousands by filing date
TRW AUTOMOTIVE HLDGS CORP87264S106COM363,601$37,393,000thousands by filing date
CAREFUSION CORP14170T101COM625,852$37,132,000thousands by filing date
INTERNATIONAL RECTIFIER CORP460254105COMMON STOCK857,586$34,222,000thousands by filing date
SIGMA ALDRICH CORP826552101COM224,286$30,784,000thousands by filing date
TIME WARNER CABLE INC88732J207COM188,265$28,633,000thousands by filing date
ALLY FINL INC COM02005N100Stock413,171$9,755,000thousands by filing date
INFINITY PHARMACEUTICALS INC45665G303COM409,715$6,922,000thousands by filing date
OREXIGEN THERAPEUTICS INC686164104COMMON STOCK1,058,656$6,421,000thousands by filing date
INTERCEPT PHARMACEUTICALS IN45845P108COM38,732$6,042,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM348,419$5,402,000thousands by filing date
T-Mobile US,Inc.872590104COM197,457$5,318,000thousands by filing date
SANDISK CORP80004CAF8NOTE 0.500%10/13,500,000$4,217,000thousands by filing dateprincipal
OPHTHOTECH CORP683745103COM91,487$4,105,000thousands by filing date
JARDEN CORP471109AL2NOTE 1.500 6/13,000,000$3,968,000thousands by filing dateprincipal
TESLA INC88160RAC5NOTE 1.250% 3/04,000,000$3,618,000thousands by filing dateprincipal
NVDA 1 12/1/1867066GAC8Bond 30/360P2 U3,000,000$3,448,000thousands by filing dateprincipal
CRM 0.25 4/1/1879466LAD6Bond 30/360P2 U3,000,000$3,420,000thousands by filing dateprincipal
YAHOO INC984332AF3NOTE 12/03,000,000$3,404,000thousands by filing dateprincipal
MOMENTA PHARMACEUTICALS INC60877T100COM264,508$3,186,000thousands by filing date
ACORDA THERAPEUTICS INC00484MAA4NOTE 1.750% 6/12,000,000$2,305,000thousands by filing dateprincipal
Apple Inc037833100COM700$2,287,000thousands by filing datecall
SYNCHRONOSS TECHNOLOGIES INC87157BAA1NOTE 0.750 8/11,750,000$1,855,000thousands by filing dateprincipal
HYPERION THERAPEUTICS INC44915N101COM73,653$1,767,000thousands by filing date
Google38259p508COM3,000$1,592,000thousands by filing date
Citigroup Inc.172967424COM26,800$1,451,000thousands by filing date
CRITEO S A SPONS ADS226718104ADR35,000$1,415,000thousands by filing date
NORTHSTAR REIT66704R704Common Stock75,075$1,321,000thousands by filing date
INSULET CORP45784PAD3NOTE 2.000% 6/11,000,000$1,193,000thousands by filing dateprincipal
GLBR 2.25 06/18302693AB2Bond 30/360P2 U1,000,000$1,050,000thousands by filing dateprincipal
DELTA AIR LINES INC COM NEW247361702Stock20,000$984,000thousands by filing date
AMERICAN AIRLINES GROUP INC COM02376R102Stock17,500$938,000thousands by filing date
BROOKDALE SR LIVING INC112463104COM25,000$916,000thousands by filing date
UNITED TECHNOLOGIES CORP913017109COM7,500$863,000thousands by filing date
UNITED AIRLS HLDGS INC COM910047109Stock12,500$836,000thousands by filing date
KINDER MORGAN INC DEL49456B119*W EXP 05/25/201185,000$795,000thousands by filing dateprincipal
AIR PRODS & CHEMS INC009158106COM5,000$721,000thousands by filing date
PLATFORM SPECIALTY PRODS COR72766Q105COM30,900$717,000thousands by filing date
ISHARES TR464288752US HOME CONS ETF25,000$648,000thousands by filing date
Morgan Stanley617446448COM15,600$606,000thousands by filing date
Union Pacific Corporation907818108COM5,000$596,000thousands by filing date
PPG INDS INC COM693506107Stock2,500$578,000thousands by filing date
INGERSOLL-RAND PLCG47791101SHS8,500$539,000thousands by filing date
Honeywell Technologies438516106COM5,000$500,000thousands by filing date
ALLISON TRANSMISSION HLDGS I01973R101COM14,000$475,000thousands by filing date
BARRICK GOLD CORP067901108COM40,000$430,000thousands by filing date
ALIMERA SCIENCES INC016259103COM76,083$422,000thousands by filing date
UNITED RENTALS INC COM911363109Stock4,000$408,000thousands by filing date
ALIBABA GROUP HLDG LTD01609W102SPONSORED ADS3,544$368,000thousands by filing date
CROSSAMERICA PARTNERS LP22758A105UT LTD PTN INT8,661$348,000thousands by filing date
ONCOGENEX PHARMACEUTICALS IN68230A106COM150,000$338,000thousands by filing date
AURINIA PHARMACEUTICALS INC COM05156V102Stock90,000$323,000thousands by filing date
NEFF CORP COM CL A640094207Stock20,900$235,000thousands by filing date
Bank of America Corp060505104COM10,000$179,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001140361-15-005300this filing2015-02-11acceptance time not in the bulk data set